Inventor · disambiguated record
Ajay Singh
Also filed as: SINGH AJAY · SINGH AJAY K · SINGH AJAY KUMAR
31 granted patents·9 pending applications·117 citations·filing 1995–2025
95Inventor score
Files withSLAYBACK PHARMA LLC13ARRAY BIOPHARMA INC7AICHER THOMAS DANIEL4AZURITY PHARMACEUTICALS INC4COUNCIL SCIENT IND RES3
Top patents by PatentIndex Score
40 records- 0197US10874671B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Dec 29, 2020·17 cites·23 claims
- 0292US11793809B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Oct 24, 2023·2 cites·9 claims
- 0392US8115059B1Gene expression modulation system for use in plants and method for modulating gene expression in plantsPALLI SUBBA REDDY·Filed 2010·Granted Feb 14, 2012·13 cites·37 claims
- 0487US8022222B2Glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·7 cites·16 claims
- 0586US12151020B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2024·Granted Nov 26, 2024·0 cites·14 claims
- 0685US9421527B2Inorganic nanoparticle deposited catalyst for hydrogenation and manufacturing method of the same, and hydrogenation for biomass derived hydrocarbon compoundsPOSTECH ACADEMY-INDUSTRY FOUND·Filed 2014·Granted Aug 23, 2016·4 cites·18 claims
- 0785US5555756AMethod of lubricating steel strip for cold rolling, particularly temper rollingINLAND STEEL CO·Filed 1995·Granted Sep 17, 1996·58 cites·32 claims
- 0884US12403140B2Pharmaceutical compositions of nilotinibAZURITY PHARMACEUTICALS INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 0983US8022223B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·5 cites·20 claims
- 1083US2025375373A1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1182US11938217B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2023·Granted Mar 26, 2024·0 cites·19 claims
- 1282US2025032508A1Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 1381US8212045B2Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2008·Granted Jul 3, 2012·4 cites·9 claims
- 1481US2025332165A1Pharmaceutical compositions of nilotinibAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1580US12138271B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·0 cites·16 claims
- 1675US12383491B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateAZURITY PHARMACEUTICALS INC·Filed 2021·Granted Aug 12, 2025·0 cites·17 claims
- 1775US11642355B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2022·Granted May 9, 2023·0 cites·15 claims
- 1875US8362037B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2008·Granted Jan 29, 2013·2 cites·23 claims
- 1973US11344858B2Micro-electrolysis reactor for ultra fast, oxidant free, C—C coupling reaction and synthesis of daclatasvir analogs thereofCOUNCIL SCIENT IND RES·Filed 2020·Granted May 31, 2022·1 cites·10 claims
- 2072US11802112B2Continuous flow micro-total process system for preparation of celecoxib and analogs thereofCOUNCIL SCIENT IND RES·Filed 2020·Granted Oct 31, 2023·1 cites·9 claims
- 2171US11311554B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2019·Granted Apr 26, 2022·0 cites·6 claims
- 2271US11110054B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Sep 7, 2021·0 cites·10 claims
- 2371US10456354B1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Oct 29, 2019·0 cites·21 claims
- 2469US8853409B2Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2012·Granted Oct 7, 2014·1 cites·32 claims
- 2567US11103502B2Pharmaceutical compositions of lurasidoneSLAYBACK PHARMA LLC·Filed 2019·Granted Aug 31, 2021·0 cites·7 claims
- 2660US9079890B2Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Jul 14, 2015·0 cites·12 claims
- 2759US11103503B2Pharmaceutical compositions of LurasidoneSLAYBACK PHARMA LLC·Filed 2020·Granted Aug 31, 2021·0 cites·12 claims
- 2855US8883828B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 11, 2014·0 cites·11 claims
- 2955US8431713B22-aminopyridine derivatives as glucokinase activatorsAICHER THOMAS DANIEL·Filed 2008·Granted Apr 30, 2013·0 cites·2 claims
- 3054US9125288B2Ion-mode plasma containmentEDWARDS W FARRELL·Filed 2011·Granted Sep 1, 2015·2 cites·14 claims
- 3153US2024294949A1Method of treatment of animal manure for biogas productionLYSTEK INT CORP·Filed 2024·Application pending·0 cites
- 3252US8354540B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2011·Granted Jan 15, 2013·0 cites·18 claims
- 3349US2023234918A1Automated diazomethane generator, reactor and solid phase quencherCOUNCIL SCIENT IND RES·Filed 2021·Application pending·0 cites
- 3447US2019262314A1Ready-to-use dexmedetomidine compositionsSLAYBACK PHARMA LLC·Filed 2019·Application pending·0 cites
- 3543US11420890B2Method of treatment of partially hydrolyzed biosolidsLYSTEK INT CORP·Filed 2020·Granted Aug 23, 2022·0 cites·7 claims
- 3643US2012126438A1Process and System for Fabrication and Surface Modification of Colloidal Carbon Spheres in Supercritical MediaRYAN KEVIN M·Filed 2011·Application pending·0 cites
- 3742US2017209373A1Multifunctional polymeric nanoparticle for diagnosis or treatment of cerebral diseases and a preparation method thereofKOREA INST SCI & TECH·Filed 2016·Application pending·0 cites
- 3841US2014256756A1Piperidinyl-substituted lactams as gpr119 modulatorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3939US8580780B26 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistALLEN JOHN GORDON·Filed 2011·Granted Nov 12, 2013·0 cites·21 claims
- 4037US8754226B2Piperidinyl-substituted lactams as GPR119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Granted Jun 17, 2014·0 cites·71 claims
Join the waitlist — get patent alerts
Get an alert when Ajay Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →